Hereditary Coproporphyria (HCP) is a rare inherited metabolic disorder that belongs to a group of conditions known as the porphyrias. These disorders affect the body’s ability to produce heme, an essential component of haemoglobin, the molecule in red blood cells that carries oxygen. While HCP is uncommon, recognising its features is important, as timely diagnosis and management can significantly improve quality of life.
What Causes Hereditary Coproporphyria?
HCP is caused by a pathogenic variant in the CPOX gene, which provides instructions for making an enzyme called coproporphyrinogen oxidase. This enzyme plays a key role in the multi-step process of heme production, known as the heme biosynthesis pathway.
When this enzyme doesn’t function properly, intermediate compounds called porphyrins and porphyrin precursors accumulate in the body. These substances are toxic at high levels and are responsible for the symptoms seen in HCP.
HCP is inherited in an autosomal dominant pattern. This means that a person only needs to inherit one altered copy of the gene to be at risk of developing the condition. However, not everyone who carries the gene variant will develop symptoms; a concept known as reduced penetrance.
Signs and Symptoms
HCP can present with a combination of acute attacks and, in some individuals, skin-related symptoms. Symptoms often appear in adulthood and may be triggered by certain environmental or lifestyle factors.
Common features include:
- Severe abdominal pain (often the most prominent symptom)
- Nausea and vomiting
- Constipation
- Muscle weakness
- Neurological symptoms such as anxiety, confusion, or seizures
- Sensitivity to sunlight, leading to blistering or fragile skin (in some cases)
Acute attacks can be severe and may require hospitalisation. Triggers can include certain medications, alcohol, hormonal changes, fasting, or infections.
Diagnosis
Diagnosing HCP can be challenging, as symptoms often mimic more common conditions. Testing typically involves measuring porphyrin levels in urine, blood, and stool, particularly during an acute episode.
Genetic testing can confirm a diagnosis by identifying a variant in the CPOX gene. This can be especially helpful for family members, as it allows for predictive testing and informed health management.
Management and Treatment
There is no cure for HCP, but it can be effectively managed with the right approach. Key strategies include:
- Avoiding known triggers, such as certain medications or fasting
- Managing acute attacks with medications like haem arginate (which helps regulate heme production)
- Pain management and supportive care during episodes
- Monitoring and managing long-term complications
For individuals with recurrent attacks, preventative therapies and specialist care may be recommended.
The Role of Genetic Counselling
Genetic counselling plays an important role in supporting individuals and families affected by HCP. A genetic counsellor can help:
- Explain the condition and inheritance pattern
- Discuss the likelihood of symptoms developing
- Facilitate genetic testing for relatives
- Provide guidance on family planning options
At Rosalind Genetics, we aim to provide personalised, compassionate care to help individuals understand their genetic risks and make informed decisions.
Final Thoughts
Although Hereditary Coproporphyria is rare, its impact can be significant, particularly when diagnosis is delayed. Increased awareness among both healthcare providers and the public is key to improving outcomes.
If you or your family have a history suggestive of a porphyria, seeking expert advice can make all the difference. Early recognition, appropriate testing, and tailored management can help individuals with HCP lead healthy, fulfilling lives.
